• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
98% Bifida Ferment Lysate
rhSOD (cosmetic grade)
Recombinant humanized collagen
Recombinant Humanized Small-molecule Collagen
Recombinant Humanized Small-molecule Collagen Solution
rhSOD

MSN group gets US FDA nod for dimethyl fumarate capsules

expresspharmaOctober 10, 2020

Tag: MSN , FDA , dimethyl fumarate capsules , ANDA

MSN Group (MSN), receives ANDA approval for dimethyl fumarate delayed release capsule. The company manufactures active pharmaceutical ingredient (API) as well as the finished formulation of dimethyl fumarate delayed-release capsules in-house.

MSN has entered into a commercial partnership with Dr Reddy’s for marketing the product in the United States.

The medicine will be available in strengths of 120 mg and 240 mg capsules in bottle count sizes of 14 and 60 capsules, respectively.

Dimethyl fumarate is a prescription medicine used to treat relapsing forms of multiple sclerosis in adults.
Currently, the company has over 100 ANDAs and 710 DMFs.

Previous:FDA issues guidance on emergency use authorisation for COVID-19 vaccines

Next:China’s experimental COVID-19 vaccine appears safe: study

Related News

Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

PRNewswireDecember 19, 2024

A New Premium Supplements Brand, Launched Officially on November 18th on IM8health.com

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

PRNewswireDecember 19, 2024

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

PRNewswireDecember 20, 2024

MSN group gets US FDA nod for dimethyl fumarate capsules | Pharmasources.com

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

PRNewswireDecember 21, 2024

Corvia Medical, Inc.announced today that it has achieved CE certification for the Corvia® Atrial Shunt System under the latest EU Medical Device Regulations (EU MDR 2017/745).

You may like
More>>

pharmaceutical Oxytocin Acetate(GMP standard product) Peptide

pharmaceutical Oxytocin Acetate(GMP standard product) Peptide
Hydroxypropyl-Beta-Cyclodextrin Oral Pharma Grade USP Standard

Hydroxypropyl-Beta-Cyclodextrin Oral Pharma Grade USP Standard
Rocuronium bromide USP/EP & its intermediate & Its impurity working standard

Rocuronium bromide USP/EP & its intermediate & Its impurity working standard
Borneol sandal

Borneol sandal
Gemfibrozil (FDA)

Gemfibrozil (FDA)
Lincomycin HCL (FDA)

Lincomycin HCL (FDA)
High Quality Good Price Thymalfasin fandachem Thymosin α1 Thymosin Alpha 1 CAS 62304-98-7 for Gym Bo

High Quality Good Price Thymalfasin fandachem Thymosin α1 Thymosin Alpha 1 CAS 62304-98-7 for Gym Bo
Irinotecan (FDA)

Irinotecan (FDA)
Marya GMP Standard Electronic Pharmaceutical Cleanroom Cargo Air Shower with High Efficiency System

Marya GMP Standard Electronic Pharmaceutical Cleanroom Cargo Air Shower with High Efficiency System
LGJ-18 Multi Manifold Standard Type Experimental Freeze Dryer

LGJ-18 Multi Manifold Standard Type Experimental Freeze Dryer

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service